MedImmune, the global biologics R&D arm of AstraZeneca, is always enthusiastic about explaining how its science benefits patients’ lives. So taking part in Cambridge’s highly successful Science Festival, which finished last weekend, is a wonderful opportunity for the company to reach out and share its activities with the wider Cambridge community.
With many thousands of visitors, the Cambridge Science Festival provides the public with opportunities to explore and discuss topics of scientific interest and, importantly, is the perfect place to raise aspirations by encouraging young people to consider a career in science. Over both weekends of the Festival, firstly in the Corn Exchange and then at the Clinical School at the Cambridge Biomedical Campus, over 35 MedImmune scientists volunteered their time to demonstrate to a continual stream of visitors to understand how new antibody medicines are found using viruses which grow in bacteria.